Suppr超能文献

主观认知下降问卷 21 在中国社区人群中的信度和效度检验。

The reliability and validity test of subjective cognitive decline questionnaire 21 with population in a Chinese community.

机构信息

Department of General Practice, XuanWu Hospital of Capital Medical University, Beijing, China.

Department of General Surgery, XuanWu Hospital of Capital Medical University, Beijing, China.

出版信息

Brain Behav. 2022 Aug;12(8):e2709. doi: 10.1002/brb3.2709. Epub 2022 Jul 21.

Abstract

BACKGROUND

Subjective cognitive decline-questionnaire 9 (SCD-Q9) was developed to detect SCD complaints at risk of mild cognitive impairment (MCI). However, our previous findings indicated that its coverage might be insufficient. To test this hypothesis, we recently translated SCD-Q21.

OBJECTIVE

To examine the reliability and validity of this translated SCD-Q21 and to explore its effectiveness for discriminating MCI from controls.

METHODS

Item analysis was performed to understand its item discrimination and homogeneity. The Cronbach's α and Spearman-Brown's split-half coefficients were calculated to test its reliability. The Kaiser-Meyer-Olkin (KMO) value, Bartlett's sphericity test, and exploratory factor analysis (EFA) were used to examine its construct validity. The content validity was evaluated using five-grade Likert scale. Finally, the SCD-Q21 scores in MCI and controls were compared.

RESULTS

The difference of each item between the extreme groups was significant. The Cronbach's α coefficient was .913 and Spearman-Brown's split-half coefficient was .894. When performing holding one-out approach, the Cronbach's α coefficient ranged from .906 to .914. The KMO value was .929 and the difference of Bartlett's Sphericity test was significant. All experts scored 5 points when assessing its content. Finally, a significant difference of score was found between MCI and NC groups.

CONCLUSIONS

The reliability and validity of the SCD-Q21 are good, which may pave a way for its application in a wider Chinese-speaking population.

摘要

背景

主观认知下降问卷 9 (SCD-Q9)旨在检测有轻度认知障碍(MCI)风险的主观认知下降(SCD)主诉。然而,我们之前的研究结果表明,它的涵盖范围可能不足。为了验证这一假设,我们最近对 SCD-Q21 进行了翻译。

目的

检验翻译后的 SCD-Q21 的信度和效度,并探索其区分 MCI 与对照组的有效性。

方法

进行项目分析以了解其项目区分度和同质性。计算克朗巴赫的α系数和斯皮尔曼-布朗的半分系数来检验其信度。使用 Kaiser-Meyer-Olkin(KMO)值、巴特利特球形检验和探索性因子分析(EFA)来检验其结构效度。采用五级李克特量表评估内容效度。最后,比较 MCI 和对照组的 SCD-Q21 评分。

结果

极端组之间每个项目的差异均有统计学意义。克朗巴赫的α系数为 0.913,斯皮尔曼-布朗的半分系数为 0.894。采用留一法时,克朗巴赫的α系数范围为 0.906-0.914。KMO 值为 0.929,巴特利特球形检验差异有统计学意义。所有专家在评估内容时均得分为 5 分。最后,MCI 组与 NC 组之间的评分差异有统计学意义。

结论

SCD-Q21 的信度和效度良好,这可能为其在更广泛的中文人群中的应用铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9392547/85cf6e474496/BRB3-12-e2709-g002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验